Effectiveness of the short-term use of Cimicifuga racemosa in the endothelial function of postmenopausal women: a double-blind, randomized, controlled trial

References

• Benjamin EJ, Virani SS, Callaway CW, et al. Heart disease and stroke statistics – 2018 update: a report from the American Heart Association. Circulation 2018;137:e67–492
   PubMed Web of Science ®Google Scholar
• Cho GJ, Lee JH, Park HT, et al. Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome. Menopause 2008;15:524–9
   PubMed Web of Science ®Google Scholar
• Kolovou GD, Bilianou HG. Influence of aging and menopause on lipids and lipoproteins in women. Angiology 2008;59:54s–7s
   PubMed Web of Science ®Google Scholar
• Mehta LS, Beckie TM, Devon HA, et al. Acute myocardial infarction in women a scientific statement from the American Heart Association. Circulation 2016;133:916–47
   PubMed Web of Science ®Google Scholar
• Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the framingham study. Am Heart J 1987;114:413–19
   PubMed Web of Science ®Google Scholar
• Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373–6
   PubMed Web of Science ®Google Scholar
• Deanfield J, Donald A, Ferri C, et al. Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the working group on endothelin and endothelial factors of The European Society of Hypertension. J Hypertens 2005;23:7–17
   PubMed Web of Science ®Google Scholar
• Hurtado R, Celani M, Geber S. Effect of short-term estrogen therapy on endothelial function: a double-blinded, randomized, controlled trial. Climacteric 2016;19:448–51
   PubMed Web of Science ®Google Scholar
• Celani MF, Hurtado R, Brandão AH, Fonseca AMM, Geber S. Short-term tibolone does not interfere with endothelial function: a double-blinded, randomized, controlled trial. Climacteric 2016;19:299–302
   PubMed Web of Science ®Google Scholar
• The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA 1995;273:199–208
   PubMed Web of Science ®Google Scholar
• Orshal JM, Khalil RR. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol 2004;286:R233–49
   PubMed Web of Science ®Google Scholar
• Boardman HM, Hartley L, Eisinga A, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev 2015;3:CD002229
   PubMed Web of Science ®Google Scholar
• Shifren JL, Schiff I. Role of hormone therapy in the management of menopause. Obstet Gynecol 2010;115:839–55
   PubMed Web of Science ®Google Scholar
• Vickers MR, Martin J, Meade TW. The women's international study of long-duration oestrogen after menopause (Wisdom): a randomised controlled trial. BMC Women’s Health 2007;7:1–17
   PubMedGoogle Scholar
• Cuzick J. Hormone replacement therapy and the risk of breast cancer. Eur J Cancer 2008;44:2344–9
   PubMed Web of Science ®Google Scholar
• Marjoribanks J, Farquhar C, Roberts H, Lethaby A, Lee J. Long-term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev 2017;171:CD004143
   Google Scholar
• The American College of Obstetricians and Gynecologists. ACOG Practice Bulletin n.141: management of menopausal symptoms. Obstet Gynecol 2014;123:202–16
   PubMed Web of Science ®Google Scholar
• Franco OH, Chowdhury R, Troup J, et al. Use of plant-based therapies and menopausal symptoms: a systematic review and meta-analysis. JAMA 2016;315:2554–63
   PubMed Web of Science ®Google Scholar
• Sarri G, Pedder H, Dias S, Guo Y, Lumsden MA. Vasomotor symptoms resulting from natural menopause: a systematic review and network meta-analysis of treatment effects from the National Institute For Health and Care Excellence guideline on menopause. BJOG 2017;124:1514–23
   PubMed Web of Science ®Google Scholar
• Huntley A. The safety of black cohosh (Actaea racemosa, Cimicifuga racemosa). Expert Opin Drug Saf 2004;3:615–23
   PubMedGoogle Scholar
• Hernández Muñoz G, Pluchino S. Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer. Maturitas 2003;44:S59–S65
   PubMed Web of Science ®Google Scholar
• Szmyd M, Lloyd V, Hallman K, et al. The effects of black cohosh on the regulation of estrogen receptor (ERα) and progesterone receptor (PR) in breast cancer cells. Breast Cancer (Dove Med Press) 2018;10:1–11
   PubMed Web of Science ®Google Scholar
• World Health Organization. Rhizoma Cimicifugae racemosae. WHO Monographs on Selected Medicinal Plants. Vol. 2. Genève: WHO; 2002:55–65
   Google Scholar
• Li W, Chen S, Fabricant D, et al. High-performance liquid chromatographic analysis of black cohosh (Cimicifuga racemosa) constituents with in-line evaporative light scattering and photodiode array detection. Anal Chim Acta 2002;471:61–75
   Web of Science ®Google Scholar
• Kruse SO, Löhning A, Pauli GF, Winterhoff H, Nahrstedt A. Fukiic and piscidic acid esters from the rhizome of Cimicifuga racemosa and the in vitro estrogenic activity of fukinolic acid. Planta Med 1999;65:763–4
   PubMed Web of Science ®Google Scholar
• Powell SL, GöDecke T, Nikolic D, et al. In vitro serotonergic activity of black cohosh and identification of N(omega)-methylserotonin as a potential active constituent. J Agric Food Chem 2008;56:11718–26
   PubMed Web of Science ®Google Scholar
• Nikolić D, Li J, Van Breemen RB. Metabolism of N(omega)-methylserotonin, a serotonergic constituent of black cohosh (Cimicifuga racemosa, L. (Nutt.)), by human liver microsomes. Biomed Chromatogr 2014;28:1647–51
   PubMed Web of Science ®Google Scholar
• Burdette JE, Liu J, Chen SN, et al. Black cohosh acts as a mixed competitive ligand and partial agonist of the serotonin receptor. J Agric Food Chem 2003;51:5661–70
   PubMed Web of Science ®Google Scholar
• Nappi RE, Malavasi B, Brundu B, Facchinetti F. Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol. Gynecol Endocrinol 2005;20:30–5
   PubMed Web of Science ®Google Scholar
• Gorach NV. Effects of Cimicifuga racemosa on the hemodynamics parameters and quality of life in perimenopausal women with arterial hypertension. Wiad Lek 2018;71:1010–14
   PubMedGoogle Scholar
• Blumenthal M, Busse WR. The German Commission e Monographs: Therapeutic Guide to Herbal Medicines. Austin: American Botanical Council; 1998
   Google Scholar
• Human medicines evaluation division list of nationally authorised medicinal products – EMA/617506/2018. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_Herbal_monograph/2017/08/WC500233056.pdf’http://www.ema.europa.eu/docs/en_GB/document_library/Herbal_-_Herbal_monograph/2017/08/WC500233056.pdf [last accessed 10 May 2019]
   Google Scholar
• Ministério da Saúde. Agência Nacional de Vigilância Sanitária. Instrução Normativa N° 5. December 11, 2008. Available from: Lista de medicamentos fitoterápicos de registro simplificado. http://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2005/int0005_11_12_2008.html [last accessed 10 May 2019]
   Google Scholar
• Newton KM, Reed SD, LaCroix AZ, Grothaus LC, Ehrlich K, Guiltinan J. Treatment of vasomotor symptoms of menopause with black cohosh, multibotanicals, soy, hormone therapy, or placebo: a randomized trial. Ann Intern Med 2006;145:869–79
   PubMed Web of Science ®Google Scholar
• Bechlioulis A, Naka KK, Kalantaridou SN, et al. Short-term hormone therapy improves sCD40L and endothelial function in early menopausal women: potential role of estrogen receptor polymorphisms. Maturitas 2012;71:389–95
   PubMed Web of Science ®Google Scholar
• Beer AM, Osmers R, Schnitker J, Bai W, Mueck AO, Meden H. Efficacy of black cohosh (Cimicifuga racemosa) medicines for treatment of menopausal symptoms – comments on major statements of the Cochrane Collaboration report 2012 ”black cohosh (Cimicifuga spp.) for menopausal symptoms (review)”. Gynecol Endocrinol 2013;29:1022–5
   PubMed Web of Science ®Google Scholar
• Beer AM, Neff A. Differentiated evaluation of extract-specific evidence on Cimicifuga racemosa's efficacy and safety for climacteric complaints. Evid Based Complement Alternat Med 2013;2013:1
   Web of Science ®Google Scholar
• von Zepelin HH, Meden H, Kostev K, Schröder-Bernhardi D, Stammwitz U, Becher H. Isopropanolic black cohosh extract and recurrence-free survival after breast cancer. Int J Clin Pharmacol Ther 2007;45:143–54
   PubMed Web of Science ®Google Scholar
• García-Pérez MA, Pineda B, Hermenegildo C, Tarín JJ, Cano A. Isopropanolic Cimicifuga racemosa is favorable on bone markers but neutral on an osteoblastic cell line. Fertil Steril 2009;91:1347–50
   PubMed Web of Science ®Google Scholar
• Bebenek M, Kemmler W, von Stengel S, Engelke K, Kalender WA. Effect of exercise and Cimicifuga racemosa (CR BNO 1055) on bone mineral density, 10-year coronary heart disease risk, and menopausal complaints: the randomized controlled Training and Cimicifuga racemosa Erlangen (TRACE) study. Menopause 2010;17:791–800
   PubMed Web of Science ®Google Scholar
• Xi S, Liske E, Wang S, et al. Effect of isopropanolic Cimicifuga racemosa extract on uterine fibroids in comparison with tibolone among patients of a recent randomized, double blind, parallel-controlled study in Chinese women with menopausal symptoms. Evid Based Complement Alternat Med 2014;2014:1
   Google Scholar
• Bechlioulis A, Kalantaridou SN, Naka KK, et al. Endothelial function, but not carotid intima-media thickness, is affected early in menopause and is associated with severity of hot flushes. J Clin Endocrinol Metab 2010;95:1199–206
   PubMed Web of Science ®Google Scholar
• Reslan OM, Khalil RA. Vascular effects of estrogenic menopausal hormone therapy. Rev Recent Clin Trials 2012;7:47–70
   PubMedGoogle Scholar
• Enbom ET, Le MD, Oesterich L, Rutgers J, French SW. Mechanism of hepatotoxicity due to black cohosh (Cimicifuga racemosa): histological, immunohistochemical and electron microscopy analysis of two liver biopsies with clinical correlation. Exp Mol Pathol 2014;96:279–83
   PubMed Web of Science ®Google Scholar
• Naser B, Schnitker J, Minkin MJ, de Arriba SG, Nolte KU, Osmers R. Suspected black cohosh hepatotoxicity: no evidence by meta-analysis of randomized controlled clinical trials for isopropanolic black cohosh extract. Menopause 2011;18:366–75
   PubMed Web of Science ®Google Scholar
• Shou C, Li J, Liu Z. Complementary and alternative medicine in the treatment of menopausal symptoms. Chin J Integr Med 2011;17:883–8
   PubMed Web of Science ®Google Scholar
• National Institute of Health. Clinical and research information on drug-induced liver injury (livertoxic database). Available from: https://livertox.nlm.nih.gov/BlackCohosh.htm [last accessed 16 Jun 2019]
   Google Scholar
• Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257–65
   PubMed Web of Science ®Google Scholar
• Ghiadoni L, Salvetti M, Muiesan ML, Taddei S. Evaluation of endothelial function by flow mediated dilation: methodological issues and clinical importance. High Blood Press Cardiovasc Prev 2015;22:17–22
   PubMed Web of Science ®Google Scholar
• Watanabe K, Oba K, Suzuki T, et al. The importance of assessment of endothelial function according to the time course of flow-mediated dilation of the brachial artery. J Nippon Med Sch 2010;77:59–61
   PubMedGoogle Scholar
• Wuttke W, Seidlová-Wuttke D, Gorkow C. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas 2003;44:S67–S77
   PubMed Web of Science ®Google Scholar
• Seidlová-Wuttke D, Hesse O, Jarry H, et al. Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17beta. Eur J Endocrinol 2003;149:351–62
   PubMed Web of Science ®Google Scholar
• Simoncini T, Genazzani AR, Liao JK. Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene. Circulation 2002;105:1368–73
   PubMed Web of Science ®Google Scholar
• Figtree GA, Lu Y, Webb CM, Collins P. Raloxifene acutely relaxes rabbit coronary arteries in vitro by an estrogen receptor-dependent and nitric oxide-dependent mechanism. Circulation 1999;100:1095–101
   PubMed Web of Science ®Google Scholar
• Arenas IA, Armstrong SJ, Xu Y, Davidge ST. Chronic tumor necrosis factor-alpha inhibition enhances no modulation of vascular function in estrogen-deficient rats. Hypertension 2005;46:76–81
   PubMed Web of Science ®Google Scholar
• Rhyu MR, Lu J, Webster DE, Fabricant DS, Farnsworth NR, Wang ZJ. Black cohosh (Actaea racemosa, Cimicifuga racemosa) behaves as a mixed competitive ligand and partial agonist at the human mu opiate receptor. J Agric Food Chem 2006;54:9852–7
   PubMed Web of Science ®Google Scholar
• Saxena PR, Villalón CM. 5-hydroxytryptamine: a chameleon in the heart. Trends Pharmacol Sci 1991;12:223–7
   PubMed Web of Science ®Google Scholar
• Kitson S. 5-Hydroxytryptamine (5-HT) receptor ligands. Curr Pharm Des 2007;13:2621–37
   PubMed Web of Science ®Google Scholar
• Seitz BM, Orer HS, Krieger-Burke T, et al. 5-HT causes splanchnic venodilation. Am J Physiol Heart Circ Physiol 2017;313:H676–86
   PubMed Web of Science ®Google Scholar
• Mercier F, Balansard J. Sur les constituants du rhizome de Cimicifuga racemosa. Soc Biol Marseille 1935;138:166–8
   Google Scholar
• Genazzani E, Sorrentino L. Vascular action of acteina: active constituent of Acataea racemosa L. Nature 1962;194:544–5
   PubMed Web of Science ®Google Scholar
• Kim EY, Lee YJ, Rhyu MR. Black cohosh (Cimicifuga racemosa) relaxes the isolated rat thoracic aorta through endothelium-dependent and -independent mechanisms. J Ethnopharmacol 2011;138:537–42
   PubMed Web of Science ®Google Scholar
• Noguchi M, Nagai M, Koeda M, et al. Vasoactive effects of cimicifugic acids C and D, and fukinolic acid in Cimicifuga rhizome. Biol Pharm Bull 1998;21:1163–8
   PubMed Web of Science ®Google Scholar
• Campos LB, Gilglioni EH, Garcia RF, et al. Cimicifuga racemosa impairs fatty acid β-oxidation and induces oxidative stress in livers of ovariectomized rats with renovascular hypertension. Free Radic Biol Med 2012;53:680–9
   PubMed Web of Science ®Google Scholar
• Tsukamoto S, Aburatani M, Ohta T. Isolation of CYP3A4 inhibitors from the black cohosh (Cimicifuga racemosa). Evid Based Complement Alternat Med 2005;2:223–6
   PubMed Web of Science ®Google Scholar
• Gödecke T, Nikolic D, Lankin DC, et al. Phytochemistry of cimicifugic acids and associated bases in Cimicifuga racemosa root extracts. Phytochem Anal 2009;20:120–33
   PubMed Web of Science ®Google Scholar